Marks Wealth’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PGEN
PCM
TCM
IAM
OCM
Marks Wealth's PGEN Position: Q3 2025 in Review
Marks Wealth sold out of Precigen (PGEN) in Q3 2025, closing a stake of 10,042 shares — an estimated $14.3K sold.
Marks Wealth first reported a position in PGEN in Q3 2024 and held it in 4 quarters. The position peaked at $14.9K in Q1 2025. 167 funds tracked by Wall St. Rank hold PGEN as of Q3 2025.
- Marks Wealth reported no remaining Precigen position as of Q3 2025 after selling out during the quarter.
- Marks Wealth sold 10,042 Precigen shares in Q3 2025, an estimated $14.3K.
- Marks Wealth first reported a position in Precigen in Q3 2024 and held it in 4 quarters.
- Marks Wealth's Precigen position peaked at $14.9K in Q1 2025.
- 167 funds tracked by Wall St. Rank held Precigen as of Q3 2025.
Based on Marks Wealth's 13F filing for Q3 2025, filed 28 Oct 2025.